Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease

Branko Malojcic*, Panteleimon Giannakopoulos, Farzaneh A. Sorond, Elsa Azevedo, Marina Diomedi, Janja Pretnar Oblak, Nicola Carraro, Marina Boban, Laszlo Olah, Stephan J. Schreiber, Aleksandra Pavlovic, Zsolt Garami, Nantan M. Bornstein, Bernhard Rosengarten

*Corresponding author for this work

Research output: Contribution to journalReview article

23 Scopus citations

Abstract

Background: The vascular contributions to neurodegeneration and neuroinflammation may be assessed by magnetic resonance imaging (MRI) and ultrasonography (US). This review summarises the methodology for these widely available, safe and relatively low cost tools and analyses recent work highlighting their potential utility as biomarkers for differentiating subtypes of cognitive impairment and dementia, tracking disease progression and evaluating response to treatment in various neurocognitive disorders. Methods: At the 9th International Congress on Vascular Dementia (Ljubljana, Slovenia, October 2015) a writing group of experts was formed to review the evidence on the utility of US and arterial spin labelling (ASL) as neurophysiological markers of normal ageing, vascular cognitive impairment (VCI) and Alzheimer's disease (AD). Original articles, systematic literature reviews, guidelines and expert opinions published until September 2016 were critically analysed to summarise existing evidence, indicate gaps in current knowledge and, when appropriate, suggest standards of use for the most widely used US and ASL applications. Results: Cerebral hypoperfusion has been linked to cognitive decline either as a risk or an aggravating factor. Hypoperfusion as a consequence of microangiopathy, macroangiopathy or cardiac dysfunction can promote or accelerate neurodegeneration, blood-brain barrier disruption and neuroinflammation. US can evaluate the cerebrovascular tree for pathological structure and functional changes contributing to cerebral hypoperfusion. Microvascular pathology and hypoperfusion at the level of capillaries and small arterioles can also be assessed by ASL, an MRI signal. Despite increasing evidence supporting the utility of these methods in detection of microvascular pathology, cerebral hypoperfusion, neurovascular unit dysfunction and, most importantly, disease progression, incomplete standardisation and missing validated cut-off values limit their use in daily routine. Conclusions: US and ASL are promising tools with excellent temporal resolution, which will have a significant impact on our understanding of the vascular contributions to VCI and AD and may also be relevant for assessing future prevention and therapeutic strategies for these conditions. Our work provides recommendations regarding the use of non-invasive imaging techniques to investigate the functional consequences of vascular burden in dementia.

Original languageEnglish (US)
Article number27
JournalBMC Medicine
Volume15
Issue number1
DOIs
StatePublished - Feb 9 2017

Keywords

  • Alzheimer disease
  • Arterial spin labelling
  • Cerebral small vessel disease
  • Transcranial Doppler sonography
  • Ultrasonography
  • Vascular cognitive impairment
  • Vascular dementia

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease'. Together they form a unique fingerprint.

  • Cite this

    Malojcic, B., Giannakopoulos, P., Sorond, F. A., Azevedo, E., Diomedi, M., Oblak, J. P., Carraro, N., Boban, M., Olah, L., Schreiber, S. J., Pavlovic, A., Garami, Z., Bornstein, N. M., & Rosengarten, B. (2017). Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease. BMC Medicine, 15(1), [27]. https://doi.org/10.1186/s12916-017-0799-3